These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16630397)

  • 1. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature.
    Kim JH; Tavassoli F; Haffty BG
    Cancer J; 2006; 12(2):92-101. PubMed ID: 16630397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression in postmastectomy chest wall relapse.
    Kim JH; Bossuyt V; Ponn T; Lannin D; Haffty BG
    Clin Cancer Res; 2005 Jul; 11(14):5199-205. PubMed ID: 16033837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally recurrent breast cancer after conservation therapy.
    Huston TL; Simmons RM
    Am J Surg; 2005 Feb; 189(2):229-35. PubMed ID: 15720997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
    Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
    Haffty BG; Hauser A; Choi DH; Parisot N; Rimm D; King B; Carter D
    Cancer; 2004 Jan; 100(2):252-63. PubMed ID: 14716758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in patients treated with mastectomy for ductal carcinoma in situ.
    Owen D; Tyldesley S; Alexander C; Speers C; Truong P; Nichol A; Wai ES
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e129-34. PubMed ID: 23195778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
    Yen TW; Hunt KK; Mirza NQ; Thomas ES; Singletary SE; Babiera GV; Meric-Bernstam F; Buchholz TA; Feig BW; Ross MI; Ames FC; Theriault RL; Kuerer HM
    Cancer; 2004 Mar; 100(5):942-9. PubMed ID: 14983489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of breast carcinoma after breast conserving treatment.
    Peterse JL; van Dongen JA; Bartelink H
    Eur J Surg Oncol; 1988 Apr; 14(2):123-6. PubMed ID: 2834239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic invasive breast cancer recurrence following curative-intent therapy for ductal carcinoma in situ.
    Al Mushawah F; Rastelli A; Pluard T; Margenthaler JA
    J Surg Res; 2012 Mar; 173(1):10-5. PubMed ID: 21696764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?].
    André G; Tunon-de-Lara C; Macgrogan G; Laharie-Mineur H; Bussieres JE; Valentin F; Barreau B; Dilhuydy MH; Dilhuydy JM; Mauriac L; Debled M; Durand M; Mathoulin S; Avril A
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):260-6. PubMed ID: 17376610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Tunon de Lara C
    Gynecol Obstet Fertil; 2008 May; 36(5):499-506. PubMed ID: 18467151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
    Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
    Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy.
    Rashtian A; Iganej S; Amy Liu IL; Natarajan S
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1016-20. PubMed ID: 18954711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence after breast ablation for ductal carcinoma in situ.
    de Jong E; Peterse JL; van Dongen JA
    Eur J Surg Oncol; 1992 Feb; 18(1):64-6. PubMed ID: 1310646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.